FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CANITROT, Y.
Right arrow Articles by HOFFMANN, J.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CANITROT, Y.
Right arrow Articles by HOFFMANN, J.-S.
(The FASEB Journal. 1999;13:1107-1111.)
© 1999 FASEB

Overexpression of DNA polymerase ß: a genomic instability enhancer process

YVAN CANITROT, MATHILDE FRÉCHET, LAURENCE SERVANT, CHRISTOPHE CAZAUX1 and JEAN-SÉBASTIEN HOFFMANN1

IPBS - CNRS UPR 9062, groupe Instabilité Génétique et Cancer, 31077 Toulouse cedex, France

1Correspondence: Jean-Sébastien Hoffmann (jseb@ipbs.fr) and Christophe Cazaux, IPBS - CNRS UPR 9062, groupe Instabilité Génétique et Cancer, 205 route de Narbonne, 31077 Toulouse cedex, France.

DNA polymerase ß (Pol ß) is the most inaccurate of the six DNA polymerases found in mammalian cells. In a normal situation, it is expressed at a constant low level and its role is believed to be restricted to repair synthesis in the base excision repair pathway participating to the genome stability. However, excess of Pol ß, found in some human tumors, could confer an increase in spontaneous mutagenesis and result in a highly mutagenic tolerance phenotype toward bifunctional DNA cross-linking anticancer drugs. Here, we present a hypothesis on the mechanisms used by Pol ß to be a genetic instability enhancer through its overexpression. We hypothesize that an excess of Pol ß perturbs the well-defined specific functions of DNA polymerases developed by the cell and propose Pol ß-mediated gap fillings during DNA transactions like repair, replication, or recombination pathways as key processes to introduce illegitimate deoxyribonucleotides or mutagenic base analogs like those produced by intracellular oxidative processes. These mechanisms may predominate during cellular nonproliferative phases in the absence of DNA replication.—Canitrot, Y., Fréchet, M., Servant, L., Cazaux, C., Hoffmann, J.-S. Overexpression of DNA polymerase ß: a genomic instability enhancer process.


Key Words: DNA replication • Pol ß • mismatch repair • nucleotide excision repair




This article has been cited by other articles:


Home page
Cancer Res.Home page
C. Bavoux, A. M. Leopoldino, V. Bergoglio, J. O-Wang, T. Ogi, A. Bieth, J.-G. Judde, S. D. J. Pena, M.-F. Poupon, T. Helleday, et al.
Up-Regulation of the Error-Prone DNA Polymerase {kappa} Promotes Pleiotropic Genetic Alterations and Tumorigenesis
Cancer Res., January 1, 2005; 65(1): 325 - 330.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Y. Canitrot, J.-P. Capp, N. Puget, A. Bieth, B. Lopez, J.-S. Hoffmann, and C. Cazaux
DNA polymerase {beta} overexpression stimulates the Rad51-dependent homologous recombination in mammalian cells
Nucleic Acids Res., September 27, 2004; 32(17): 5104 - 5112.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. Li, S. H. Berger, and M. D. Wyatt
Involvement of base excision repair in response to therapy targeted at thymidylate synthase
Mol. Cancer Ther., June 1, 2004; 3(6): 747 - 753.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Bergoglio, M.-J. Pillaire, M. Lacroix-Triki, B. Raynaud-Messina, Y. Canitrot, A. Bieth, M. Gares, M. Wright, G. Delsol, L. A. Loeb, et al.
Deregulated DNA Polymerase {beta} Induces Chromosome Instability and Tumorigenesis
Cancer Res., June 1, 2002; 62(12): 3511 - 3514.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Frosina
Counteracting spontaneous transformation via overexpression of rate-limiting DNA base excision repair enzymes
Carcinogenesis, September 1, 2001; 22(9): 1335 - 1341.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Louat, L. Servant, M.-P. Rols, A. Bieth, J. Teissie, J.-S. Hoffmann, and C. Cazaux
Antitumor Activity of 2',3'-Dideoxycytidine Nucleotide Analog Against Tumors Up-Regulating DNA Polymerase beta
Mol. Pharmacol., September 1, 2001; 60(3): 553 - 558.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Kobune, Y. Xu, C. Baum, M. R. Kelley, and D. A. Williams
Retrovirus-mediated Expression of the Base Excision Repair Proteins, Formamidopyrimidine DNA Glycosylase or Human Oxoguanine DNA Glycosylase, Protects Hematopoietic Cells from N,N',N''-Triethylenethiophosphoramide (thioTEPA)-induced Toxicity in Vitro and in Vivo
Cancer Res., July 1, 2001; 61(13): 5116 - 5125.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. Rusyn, M. F. Denissenko, V. A. Wong, B. E. Butterworth, M. L. Cunningham, P. B. Upton, R. G. Thurman, and J. A. Swenberg
Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency
Carcinogenesis, December 1, 2000; 21(12): 2141 - 2145.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y. CANITROT, J.-S. HOFFMANN, P. CALSOU, H. HAYAKAWA, B. SALLES, and C. CAZAUX
Nucleotide excision repair DNA synthesis by excess DNA polymerase {beta}: a potential source of genetic instability in cancer cells
FASEB J, September 1, 2000; 14(12): 1765 - 1774.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Vaisman and S. G. Chaney
The Efficiency and Fidelity of Translesion Synthesis past Cisplatin and Oxaliplatin GpG Adducts by Human DNA Polymerase beta
J. Biol. Chem., April 21, 2000; 275(17): 13017 - 13025.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. R. Loeb and L. A. Loeb
Significance of multiple mutations in cancer
Carcinogenesis, March 1, 2000; 21(3): 379 - 385.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The Federation of American Societies for Experimental Biology.